Clinical relevance and igg subclass determination of Non-HLA antibodies identified using endothelial cell precursors isolated from donor blood

Transplantation

Volumn 92, Issue 1, 2011, Pages 54-60

  Jackson, Annette M ^a,c   Lucas, Donna P ^a   Melancon, J Keith ^b   Desai, Niraj M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Immunogenetics Laboratory   (United States)

Author keywords

Alloantibodies; Endothelial cell; Kidney transplantation; Non HLA antibodies; Rejection

Indexed keywords

ALLOANTIBODY; COMPLEMENT; CREATININE; ENDOTHELIAL CELL ANTIBODY; HLA ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M; IMMUNOGLOBULIN SUBCLASS; MYCOPHENOLIC ACID; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CELL ISOLATION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENDOTHELIAL PROGENITOR CELL; FEMALE; FLOW CYTOMETRY; HLA MATCHING; HUMAN; IMMUNOASSAY; INCIDENCE; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

ADULT; ADULT STEM CELLS; AGED; COMPLEMENT ACTIVATION; CREATININE; ENDOTHELIAL CELLS; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOGLOBULIN G; ISOANTIBODIES; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED;

EID: 79959635250     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31821b60e9     Document Type: Article

References (40)

1. Sumitran-Karuppan S, Tyden G, Reinholt F, et al. Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells. Transpl Immunol 1997; 5: 321.
2. Perrey C, Brenchley PE, Johnson RW, et al. An association between antibodies specific for endothelial cells and renal transplant failure. Transpl Immunol 1998; 6: 101.
3. Mizutani K, Terasaki P, Bignon JD, et al. Association of kidney transplant failure and antibodies against MICA. Hum Immunol 2006; 67: 683.
4. Amico P, Honger G, Bielmann D, et al. Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies. Transplantation 2008; 85: 1557.
5. Sun Q, Liu Z, Chen J, et al. Circulating anti-endothelial cell antibodies are associated with poor outcome in renal allograft recipients with acute rejection. Clin J Am Soc Nephrol 2008; 3: 1479.
6. Opelz G. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet 2005; 365: 1570.
7. Jurcevic S, Ainsworth ME, Pomerance A, et al. Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. Transplantation 2001; 71: 886.
8. Sumitran-Holgersson S, Wilczek HE, Holgersson J, et al. Identification of the nonclassical HLA molecules, mica, as targets for humoral immunity associated with irreversible rejection of kidney allografts. Transplantation 2002; 74: 268.
9. Joosten SA, Sijpkens YW, van Ham V, et al. Antibody response against the glomerular basement membrane protein agrin in patients with transplant glomerulopathy. Am J Transplant 2005; 5: 383.
10. Zwirner NW, Marcos CY, Mirbaha F, et al. Identification of MICA as a new polymorphic alloantigen recognized by antibodies in sera of organ transplant recipients. Hum Immunol 2000; 61: 917.
11. Dragun D, Muller DN, Brasen JH, et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 2005; 352: 558.
12. Li L, Wadia P, Chen R, et al. Identifying compartment-specific non- HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures. Proc Natl Acad Sci USA 2009; 106: 4148.
13. Vermehren D, Sumitran-Holgersson S. Isolation of precursor endothelial cells from peripheral blood for donor-specific crossmatching before organ transplantation. Transplantation 2002; 74: 1479.
14. Breimer ME, Rydberg L, Jackson AM, et al. Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation. Transplantation 2009; 87: 549.
15. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713.
16. Jefferis R. Antibody therapeutics: Isotype and glycoform selection. Expert Opin Biol Ther 2007; 7: 1401.
17. Eng HS, Bennett G, Tsiopelas E, et al. Anti-HLA donor-specific antibodies detected in positive B-cell crossmatches by Luminex predict late graft loss. AmJ Transplant 2008; 8: 2335.
18. Regan J, Monteiro F, Speiser D, et al. Pretransplant rejection risk assessment through enzyme-linked immunosorbent assay analysis of anti-HLA class I antibodies. Am J Kidney Dis 1996; 28: 92.
19. Colvin RB. Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis. J Am Soc Nephrol 2007; 18: 1046.
20. Murata K, Baldwin WM III. Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody- mediated rejection. Transplant Rev (Orlando) 2009; 23: 139.
21. Lucisano Valim YM, Lachmann PJ. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: A systematic study using chimaeric anti-NIP antibodies with human Fc regions. Clin Exp Immunol 1991; 84: 1.
22. Sumitran-Holgersson S, Holgersson J. Clinical importance of non- HLA antibodies in solid organ transplantation. Curr Opin Organ Transpl 2006; 11: 425.
23. Zhang X, Reed EF. Effect of antibodies on endothelium. Am J Transplant 2009; 9: 2459.
24. Dragun D. Humoral responses directed against non-human leukocyte antigens in solid-organ transplantation. Transplantation 2008; 86: 1019.
25. Sata M, Walsh K. TNFalpha regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation. Nat Med 1998; 4: 415.
26. Lucchiari N, Panajotopoulos N, Xu C, et al. Antibodies eluted from acutely rejected renal allografts bind to and activate human endothelial cells. Hum Immunol 2000; 61: 518.
27. Ferrero E, Bondanza A, Leone BE, et al. CD14 CD34 peripheral blood mononuclear cells migrate across endothelium and give rise to immunostimulatory dendritic cells. J Immunol 1998; 160: 2675.
28. Randolph GJ, Beaulieu S, Lebecque S, et al. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 1998; 282: 480.
29. Denton MD, Geehan CS, Alexander SI, et al. Endothelial cells modify the costimulatory capacity of transmigrating leukocytes and promote CD28-mediated CD4() T cell alloactivation. J Exp Med 1999; 190: 555.
30. Berg LP, James MJ, Alvarez-Iglesias M, et al. Functional consequences of noncognate interactions between CD4 memory T lymphocytes and the endothelium. J Immunol 2002; 168: 3227.
31. Sumitran-Holgersson S, Ge X, Karrar A, et al. A novel mechanism of liver allograft rejection facilitated by antibodies to liver sinusoidal endothelial cells. Hepatology 2004; 40: 1211.
32. Le Bas-Bernardet S, Hourmant M, Coupel S, et al. Non-HLA-type endothelial cell reactive alloantibodies in pre-transplant sera of kidney recipients trigger apoptosis. Am J Transplant 2003; 3: 167.
33. Morariu AM, Schuurs TA, Leuvenink HG, et al. Early events in kidney donation: Progression of endothelial activation, oxidative stress and tubular injury after brain death. Am J Transplant 2008; 8: 933.
34. Rao DA, Pober JS. Endothelial injury, alarmins, and allograft rejection. Crit Rev Immunol 2008; 28: 229.
35. Aalberse RC, Stapel SO, Schuurman J, et al. Immunoglobulin G4: An odd antibody. Clin Exp Allergy 2009; 39: 469.
36. Haas M, Montgomery RA, Segev DL, et al. Subclinical acute antibodymediated rejection in positive crossmatch renal allografts. Am J Transplant 2007; 7: 576.
37. Bray RA. Flow cytometry in the transplant laboratory. Ann NY Acad Sci 1993; 677: 138.
38. Zachary AA, Lucas DP, Detrick B, et al. Naturally occurring interference in Luminex assays for HLA-specific antibodies: Characteristics and resolution. Hum Immunol 2009; 70: 496.
39. Hetrick SJ, Schillinger KP, Zachary AA, et al. Impact of pronase on flow cytometric crossmatch outcome. Hum Immunol 2011; 72: 330.
40. Deregibus MC, Cantaluppi V, Calogero R, et al. Endothelial progenitor cell-derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 2007; 110: 2440.